Literature DB >> 24513531

On the structural organization of the intracellular domains of CFTR.

Oscar Moran1.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a multidomain membrane protein forming an anion selective channel. Mutations in the gene encoding CFTR cause cystic fibrosis (CF). The intracellular side of CFTR constitutes about 80% of the total mass of the protein. This region includes domains involved in ATP-dependent gating and regulatory protein kinase-A phosphorylation sites. The high-resolution molecular structure of CFTR has not yet been solved. However, a range of lower resolution structural data, as well as functional biochemical and electrophysiological data, are now available. This information has enabled the proposition of a working model for the structural architecture of the intracellular domains of the CFTR protein.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CFTR; Cystic fibrosis; NBD; Regulatory domain; Structure

Mesh:

Substances:

Year:  2014        PMID: 24513531     DOI: 10.1016/j.biocel.2014.01.024

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  10 in total

1.  Beyond cystic fibrosis transmembrane conductance regulator (CFTR) single channel kinetics: implications for therapeutic intervention.

Authors:  Carmel M McNicholas
Journal:  J Physiol       Date:  2017-02-15       Impact factor: 5.182

Review 2.  NM23 proteins: innocent bystanders or local energy boosters for CFTR?

Authors:  Richmond Muimo; Hani Mm Alothaid; Anil Mehta
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

3.  Functional and pharmacological induced structural changes of the cystic fibrosis transmembrane conductance regulator in the membrane solved using SAXS.

Authors:  Debora Baroni; Olga Zegarra-Moran; Oscar Moran
Journal:  Cell Mol Life Sci       Date:  2014-10-02       Impact factor: 9.261

4.  A stable human-cell system overexpressing cystic fibrosis transmembrane conductance regulator recombinant protein at the cell surface.

Authors:  Ellen Hildebrandt; Alok Mulky; Haitao Ding; Qun Dai; Andrei A Aleksandrov; Bekim Bajrami; Pamela Ann Diego; Xing Wu; Marjorie Ray; Anjaparavanda P Naren; John R Riordan; Xudong Yao; Lawrence J DeLucas; Ina L Urbatsch; John C Kappes
Journal:  Mol Biotechnol       Date:  2015-05       Impact factor: 2.695

Review 5.  Molecular modelling and molecular dynamics of CFTR.

Authors:  Isabelle Callebaut; Brice Hoffmann; Pierre Lehn; Jean-Paul Mornon
Journal:  Cell Mol Life Sci       Date:  2016-10-07       Impact factor: 9.261

Review 6.  The gating of the CFTR channel.

Authors:  Oscar Moran
Journal:  Cell Mol Life Sci       Date:  2016-10-01       Impact factor: 9.261

Review 7.  Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives.

Authors:  Béla Z Schmidt; Jérémy B Haaf; Teresinha Leal; Sabrina Noel
Journal:  Clin Pharmacol       Date:  2016-09-21

Review 8.  Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.

Authors:  Samuel Estabrooks; Jeffrey L Brodsky
Journal:  Int J Mol Sci       Date:  2020-01-10       Impact factor: 5.923

9.  Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.

Authors:  Giulia Amico; Chiara Brandas; Oscar Moran; Debora Baroni
Journal:  Int J Mol Sci       Date:  2019-11-01       Impact factor: 5.923

Review 10.  Gene therapy for cystic fibrosis: new tools for precision medicine.

Authors:  Alex Cho; Elena N Huang; Jin-A Lee; Yiming Xu; Henry Quach; Jim Hu; Amy P Wong
Journal:  J Transl Med       Date:  2021-10-30       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.